Published Date: 18 Feb 2023
Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis
Read Full NewsThe thymus is not routinely considered during thoracic radiotherapy planning, but new findings suggest that may need to change.
Adding rusfertide to standard-of-care treatment cut phlebotomy rates by more than half in the phase 3 VERIFY trial.
1.
Telemedicine Not Reaching Rural Psychiatric Patients
2.
Loneliness and social isolation linked to heightened risk of death in those with cancer
3.
Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.
4.
According to a study, breast cancer in Syrian refugees tends to be diagnosed at an earlier stage and with more advanced tumors.
5.
Non-small cell lung cancer patients who are ineligible for platinum-based chemotherapy benefit from atezolizumab monotherapy.
1.
Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer
2.
Quality of Life Following Functional Restoration of Bone Marrow Reserve
3.
Tumor Microenvironment Reprogramming Through Stromal Modulation
4.
Ferroptosis-Modulating Nanocarriers for Solid Tumor Therapy
5.
Evolutionary Intelligence for Oncology Research Optimization
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
2.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
3.
Navigating the Complexities of Ph Negative ALL - Part II
4.
Recognizing Symptoms That May Require Cancer Evaluation
5.
Diagnosis and Management in Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation